<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE Annotation PUBLIC "-//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN" "../GENIAtypes/GENIA_event_20.dtd">
<Annotation created="27/01/2007" annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=10359895" creator="Junko Matsuura">
<PubmedArticleSet>
<PubmedArticle>
<MedlineCitation>
<PMID>10359895</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Binding of <term sem="Protein_molecule" id="T1" lex="YY1">YY1</term> and <term sem="Protein_molecule" id="T2" lex="Oct1">Oct1</term> to a <term sem="DNA_domain_or_region" id="A1">novel element</term> that downregulates expression of <term sem="Protein_molecule" id="T3" lex="IL-5">IL-5</term> in human <term sem="Cell_natural" id="T4" lex="T_cell">T cells</term>.</sentence>
<event id="E1">
<type class="Binding" />
<theme idref="A1" />
<theme idref="T1" />
<clue><clueType>Binding</clueType> <linkTheme>of</linkTheme> YY1 and Oct1 <linkTheme>to</linkTheme> a novel element that downregulates expression of IL-5 in human T cells.</clue>
</event>
<event id="E2">
<type class="Binding" />
<theme idref="A1" />
<theme idref="T2" />
<clue><clueType>Binding</clueType> <linkTheme>of</linkTheme> YY1 and Oct1 <linkTheme>to</linkTheme> a novel element that downregulates expression of IL-5 in human T cells.</clue>
</event>
<event id="E3">
<type class="Gene_expression" />
<theme idref="T3" />
<clue>Binding of YY1 and Oct1 to a novel element that downregulates <clueType>expression</clueType> <linkTheme>of</linkTheme> IL-5 <clueLoc>in human T cells.</clueLoc></clue>
</event>
<event id="E4">
<type class="Negative_regulation" />
<theme idref="E3" />
<cause idref="A1" />
<clue>Binding of YY1 and Oct1 to a novel element that <clueType>downregulates</clueType> expression of IL-5 in human T cells.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">BACKGROUND: <term sem="Protein_molecule" id="T5" lex="IL-5">IL-5</term> controls development of <term sem="Other" id="T6" lex="eosinophilia">eosinophilia</term> and has been shown to be involved in the pathogenesis of <term sem="Other" id="T7" lex="allergic_disease">allergic diseases</term>.</sentence>
<event id="E5">
<type class="Cellular_physiological_process" />
<theme idref="T6" />
<clue>BACKGROUND: IL-5 controls <clueType>development</clueType> <linkTheme>of</linkTheme> eosinophilia and has been shown to be involved in the pathogenesis of allergic diseases.</clue>
</event>
<event id="E6">
<type class="Regulation" />
<theme idref="E5" />
<cause idref="T5" />
<clue>BACKGROUND: IL-5 <clueType>controls</clueType> development of eosinophilia and has been shown to be involved in the pathogenesis of allergic diseases.</clue>
</event>
<event id="E7">
<type class="Positive_regulation" />
<theme idref="T7" />
<clue>BACKGROUND: IL-5 controls development of eosinophilia and has been shown to be involved in the <clueType>pathogenesis</clueType> <linkTheme>of</linkTheme> allergic diseases.</clue>
<comment>CAUTION:cluetype</comment>
</event>
<event id="E8">
<type class="Regulation" />
<theme idref="E7" />
<cause idref="T5" />
<clue>BACKGROUND: IL-5 controls development of eosinophilia and has been shown to be <clueType>involved</clueType> <linkTheme>in</linkTheme> the pathogenesis of allergic diseases.</clue>
</event>
<sentence id="S3">In both <cons sem="(AND Other Other)" id="T8" lex="(AND atopic_asthma nonatopic_asthma)"><frag id="F1">atopic</frag> and <frag id="F2">nonatopic</frag> <frag id="F3">asthma</frag></cons>, elevated <term sem="Protein_molecule" id="T9" lex="IL-5">IL-5</term> has been detected in <term sem="Tissue_natural" id="T10" lex="peripheral_blood">peripheral blood</term> and the <term sem="Body_region" id="T11" lex="airway">airways</term>.</sentence>
<event id="E300">
<type class="Positive_regulation" />
<theme idref="T9" />
<clue><clueLoc>In</clueLoc> both <clueLoc>atopic</clueLoc> and nonatopic <clueLoc>asthma</clueLoc>, <clueType>elevated</clueType> IL-5 has been detected <clueLoc>in peripheral blood</clueLoc> and the airways.</clue>
</event>
<event id="E301">
<type class="Positive_regulation" />
<theme idref="T9" />
<clue><clueLoc>In</clueLoc> both <clueLoc>atopic</clueLoc> and nonatopic <clueLoc>asthma</clueLoc>, <clueType>elevated</clueType> IL-5 has been detected <clueLoc>in</clueLoc> peripheral blood and <clueLoc>the airways</clueLoc>.</clue>
</event>
<event id="E302">
<type class="Positive_regulation" />
<theme idref="T9" />
<clue><clueLoc>In</clueLoc> both atopic and <clueLoc>nonatopic asthma</clueLoc>, <clueType>elevated</clueType> IL-5 has been detected <clueLoc>in peripheral blood</clueLoc> and the airways.</clue>
</event>
<event id="E303">
<type class="Positive_regulation" />
<theme idref="T9" />
<clue><clueLoc>In</clueLoc> both atopic and <clueLoc>nonatopic asthma</clueLoc>, <clueType>elevated</clueType> IL-5 has been detected <clueLoc>in</clueLoc> peripheral blood and <clueLoc>the airways</clueLoc>.</clue>
</event>
<sentence id="S4"><term sem="Protein_molecule" id="T12" lex="IL-5">IL-5</term> is produced mainly by activated <term sem="Cell_natural" id="T13" lex="T_cell">T cells</term>, and its expression is regulated at the <term sem="Other" id="T14" lex="transcriptional_level">transcriptional level</term>.</sentence>
<event id="E10">
<type class="Gene_expression" />
<theme idref="T12" />
<clue>IL-5 is <clueType>produced</clueType> mainly <clueLoc>by activated T cells</clueLoc>, and its expression is regulated at the transcriptional level.</clue>
</event>
<event id="E11">
<type class="Regulation" />
<theme idref="E10" />
<clue>IL-5 is produced mainly by activated T cells, and <corefTheme>its expression</corefTheme> is <clueType>regulated</clueType> at the <clueType>transcriptional</clueType> level.</clue>
</event>
<event id="E12">
<type class="Physiological_process" />
<theme idref="T13" />
<clue>IL-5 is produced mainly by <clueType>activated</clueType> T cells, and its expression is regulated at the transcriptional level.</clue>
</event>
<sentence id="S5">OBJECTIVE: This study focuses on the functional analysis of the <term sem="DNA_domain_or_region" id="T15" lex="human_IL-5_(hIL-5)_promoter">human IL-5 (hIL-5) promoter</term> and characterization of cis -regulatory elements and <term sem="Protein_family_or_group" id="A2">transcription factors</term> involved in the suppression of <term sem="Protein_molecule" id="T16" lex="IL-5">IL-5</term> transcription in <term sem="Cell_natural" id="T17" lex="T_cell">T cells</term>.</sentence>
<event id="E13">
<type class="Transcription" />
<theme idref="T16" />
<clue>OBJECTIVE: This study focuses on the functional analysis of the human IL-5 (hIL-5) promoter and characterization of cis -regulatory elements and transcription factors involved in the suppression of IL-5 <clueType>transcription</clueType> in T cells.</clue>
</event>
<event id="E14">
<type class="Negative_regulation" />
<theme idref="E13" />
<clue>OBJECTIVE: This study focuses on the functional analysis of the human IL-5 (hIL-5) promoter and characterization of cis -regulatory elements and transcription factors involved in the <clueType>suppression</clueType> of IL-5 transcription in T cells.</clue>
</event>
<event uncertainty="doubtful" id="E15">
<type class="Regulation" />
<theme idref="E14" />
<cause idref="A2" />
<clue>OBJECTIVE: This study focuses on the functional analysis of the human IL-5 (hIL-5) promoter and characterization of cis -regulatory elements and transcription factors <clueType>involved</clueType> <linkTheme>in</linkTheme> the suppression of IL-5 transcription <clueLoc>in T cells</clueLoc>.</clue>
</event>
<sentence id="S6">METHODS: Methods used in this study include <term sem="Other" id="T18" lex="DNase_I_footprint_assay"><term sem="Protein_molecule" id="T19" lex="DNase_I">DNase I</term> footprint assays</term>, <term sem="Other" id="T20" lex="electrophoretic_mobility_shift_assay">electrophoretic mobility shift assays</term>, and functional analysis by <term sem="Other" id="T21" lex="mammalian_cell_transfection">mammalian cell transfection</term> involving <term sem="Other" id="T22" lex="deletion_analysis">deletion analysis</term> and <term sem="Other" id="T23" lex="site-directed_mutagenesis">site-directed mutagenesis</term>.</sentence>
<sentence id="S7">RESULTS: We identified 5 <term sem="DNA_domain_or_region" id="T24" lex="protein_binding_region"><term sem="Protein_molecule" id="A3">protein</term> binding regions</term> (<term sem="DNA_domain_or_region" id="T25" lex="BR">BRs</term>) located within the <term sem="DNA_domain_or_region" id="T26" lex="proximal_hIL-5_promoter">proximal <term sem="DNA_domain_or_region" id="T27" lex="hIL-5_promoter">hIL-5 promoter</term></term>.</sentence>
<event id="E16">
<type class="Binding" />
<theme idref="T25" />
<theme idref="A3" />
<clue>RESULTS: We identified 5 protein <clueType>binding</clueType> regions (BRs) located within the proximal hIL-5 promoter.</clue>
</event>
<sentence id="S8">Functional analysis indicates that the <term sem="DNA_domain_or_region" id="T28" lex="BR">BRs</term> are involved in control of <term sem="Other" id="T29" lex="hIL-5_promoter_activity"><term sem="DNA_domain_or_region" id="T30" lex="hIL-5_promoter">hIL-5 promoter</term> activity</term>.</sentence>
<event id="E17">
<type class="Regulation" />
<theme idref="T30" />
<clue>Functional analysis indicates that the BRs are involved in <clueType>control</clueType> <linkTheme>of</linkTheme> hIL-5 promoter activity.</clue>
</event>
<event id="E18">
<type class="Correlation" />
<theme idref="T28" />
<theme idref="E17" />
<clue><clueExperiment>Functional analysis</clueExperiment> indicates that the BRs are <clueType>involved</clueType> <linkTheme>in</linkTheme> control of hIL-5 promoter activity.</clue>
</event>
<sentence id="S9">Two of these regions, <term sem="DNA_domain_or_region" id="T31" lex="BR3">BR3</term> and <term sem="DNA_domain_or_region" id="T32" lex="BR4">BR4</term> located at positions -102 to -73, have not previously been described as regulators of <term sem="Other" id="T33" lex="IL-5_expression"><term sem="Protein_molecule" id="T34" lex="IL-5">IL-5</term> expression</term> in <term sem="Cell_natural" id="T35" lex="T_cell">T cells</term>.</sentence>
<event id="E19">
<type class="Gene_expression" />
<theme idref="T34" />
<clue>Two of these regions, BR3 and BR4 located at positions -102 to -73, have not previously been described as regulators of IL-5 <clueType>expression</clueType> <clueLoc>in T cells</clueLoc>.</clue>
</event>
<event id="E20">
<type class="Regulation" />
<theme idref="E19" />
<cause idref="T31" />
<clue>Two of these regions, BR3 and BR4 located at positions -102 to -73, have not previously been described as <clueType>regulators</clueType> <linkTheme>of</linkTheme> IL-5 expression in T cells.</clue>
</event>
<event id="E21">
<type class="Regulation" />
<theme idref="E19" />
<cause idref="T32" />
<clue>Two of these regions, BR3 and BR4 located at positions -102 to -73, have not previously been described as <clueType>regulators</clueType> <linkTheme>of</linkTheme> IL-5 expression in T cells.</clue>
</event>
<sentence id="S10">We show that the <term sem="DNA_domain_or_region" id="T36" lex="BR3">BR3</term> sequence contains a novel <term sem="DNA_family_or_group" id="T37" lex="negative_regulatory_element">negative regulatory element</term> located at positions -90 to -79 of the <term sem="DNA_domain_or_region" id="T38" lex="hIL-5_promoter">hIL-5 promoter</term>, which binds <term sem="Protein_molecule" id="T39" lex="Oct1">Oct1</term>, <term sem="Protein_family_or_group" id="T40" lex="octamer-like_nuclear_factor">octamer-like</term>, and <term sem="Protein_family_or_group" id="T41" lex="YY1_nuclear_factor"><term sem="Protein_molecule" id="T42" lex="YY1">YY1</term> <term sem="Protein_molecule" id="A50">nuclear factors</term></term>.</sentence>
<event id="E22">
<type class="Binding" />
<theme idref="T37" />
<theme idref1="A50" idref="T39" />
<clue>We show that the BR3 sequence contains a novel negative regulatory element located at positions -90 to -79 of the hIL-5 promoter, which <clueType>binds</clueType> Oct1, octamer-like, and YY1 nuclear factors.</clue>
</event>
<event id="E23">
<type class="Binding" />
<theme idref="T37" />
<theme idref1="A50" idref="T40" />
<clue>We show that the BR3 sequence contains a novel negative regulatory element located at positions -90 to -79 of the hIL-5 promoter, which <clueType>binds</clueType> Oct1, octamer-like, and YY1 nuclear factors.</clue>
</event>
<event id="E24">
<type class="Binding" />
<theme idref="T37" />
<theme idref="T41" />
<clue>We show that the BR3 sequence contains a novel negative regulatory element located at positions -90 to -79 of the hIL-5 promoter, which <clueType>binds</clueType> Oct1, octamer-like, and YY1 nuclear factors.</clue>
</event>
<event id="E25">
<type class="Negative_regulation" />
<theme idref="T38" />
<cause idref="T37" />
<clue>We show that the BR3 sequence contains a novel <clueType>negative regulatory</clueType> element located at positions -90 to -79 of the hIL-5 promoter, which binds Oct1, octamer-like, and YY1 nuclear factors.</clue>
</event>
<sentence id="S11">Substitution mutations, which abolished binding of these proteins to the <term sem="DNA_domain_or_region" id="T43" lex="BR3_sequence"><term sem="DNA_domain_or_region" id="T44" lex="BR3">BR3</term> sequence</term>, significantly increased <term sem="DNA_domain_or_region" id="T45" lex="hIL-5_promoter">hIL-5 promoter</term> activity in <term sem="Cell_natural" id="T46" lex="activated_T_cell">activated <term sem="Cell_natural" id="A6">T cells</term></term>.</sentence>
<event id="E200">
<type class="Mutagenesis" />
<theme idref="T43" />
<clue><clueType>Substitution mutations</clueType>, which abolished binding of these proteins to the BR3 sequence, significantly increased hIL-5 promoter activity in activated T cells.</clue>
</event>
<event id="E201">
<type class="Binding" />
<theme idref1="A50" idref="T39" />
<theme idref="T43" />
<clue>Substitution mutations, which abolished <clueType>binding</clueType> <linkTheme>of</linkTheme> <corefTheme idref1="T39">these proteins</corefTheme> <linkTheme>to</linkTheme> the BR3 sequence, significantly increased hIL-5 promoter activity in activated T cells.</clue>
</event>
<event id="E202">
<type class="Binding" />
<theme idref1="A50" idref="T40" />
<theme idref="T43" />
<clue>Substitution mutations, which abolished <clueType>binding</clueType> <linkTheme>of</linkTheme> <corefTheme idref1="T40">these proteins</corefTheme> <linkTheme>to</linkTheme> the BR3 sequence, significantly increased hIL-5 promoter activity in activated T cells.</clue>
</event>
<event id="E203">
<type class="Binding" />
<theme idref="T41" />
<theme idref="T43" />
<clue>Substitution mutations, which abolished <clueType>binding</clueType> <linkTheme>of</linkTheme> <corefTheme idref1="T41">these proteins</corefTheme> <linkTheme>to</linkTheme> the BR3 sequence, significantly increased hIL-5 promoter activity in activated T cells.</clue>
</event>
<event id="E204">
<type class="Negative_regulation" />
<theme idref="E201" />
<cause idref="E200" />
<clue>Substitution mutations, which <clueType>abolished</clueType> binding of these proteins to the BR3 sequence, significantly increased hIL-5 promoter activity in activated T cells.</clue>
</event>
<event id="E205">
<type class="Negative_regulation" />
<theme idref="E202" />
<cause idref="E200" />
<clue>Substitution mutations, which <clueType>abolished</clueType> binding of these proteins to the BR3 sequence, significantly increased hIL-5 promoter activity in activated T cells.</clue>
</event>
<event id="E206">
<type class="Negative_regulation" />
<theme idref="E203" />
<cause idref="E200" />
<clue>Substitution mutations, which <clueType>abolished</clueType> binding of these proteins to the BR3 sequence, significantly increased hIL-5 promoter activity in activated T cells.</clue>
</event>
<event id="E26">
<type class="Positive_regulation" />
<theme idref="T45" />
<cause idref="E200" />
<clue>Substitution mutations, which abolished binding of these proteins to the BR3 sequence, significantly <clueType>increased</clueType> hIL-5 promoter activity <clueLoc>in activated T cells.</clueLoc></clue>
</event>
<event id="E33">
<type class="Physiological_process" />
<theme idref="A6" />
<clue>Substitution mutations, which abolished binding of these proteins to the BR3 sequence, significantly increased hIL-5 promoter activity in <clueType>activated</clueType> T cells.</clue>
</event>
<sentence id="S12">CONCLUSION: We suggest that <term sem="Protein_molecule" id="T47" lex="Oct1">Oct1</term>, <term sem="Protein_molecule" id="T48" lex="YY1">YY1</term>, and <term sem="Protein_family_or_group" id="T49" lex="octamer-like_factor">octamer-like factors</term> binding to the <term sem="DNA_domain_or_region" id="A7"><term sem="DNA_domain_or_region" id="T50" lex="-90/-79_sequence">-90/-79 sequence</term> within the <term sem="DNA_domain_or_region" id="T51" lex="proximal_IL-5_promoter">proximal <term sem="Protein_molecule" id="T52" lex="IL-5">IL-5</term> promoter</term></term> are involved in suppression of <term sem="Other" id="T53" lex="IL-5_transcription"><term sem="Protein_molecule" id="T54" lex="IL-5">IL-5</term> transcription</term> in <term sem="Cell_natural" id="T55" lex="T_cell">T cells</term>.</sentence>
<event id="E34">
<type class="Binding" />
<theme idref="T47" />
<theme idref="A7" />
<clue>CONCLUSION: We suggest that Oct1, YY1, and octamer-like factors <clueType>binding</clueType> <linkTheme>to</linkTheme> the -90/-79 sequence within the proximal IL-5 promoter are involved in suppression of IL-5 transcription in T cells.</clue>
<comment>TPS: A7</comment>
</event>
<event id="E35">
<type class="Binding" />
<theme idref="T48" />
<theme idref="A7" />
<clue>CONCLUSION: We suggest that Oct1, YY1, and octamer-like factors <clueType>binding</clueType> <linkTheme>to</linkTheme> the -90/-79 sequence within the proximal IL-5 promoter are involved in suppression of IL-5 transcription in T cells.</clue>
</event>
<event id="E36">
<type class="Binding" />
<theme idref="T49" />
<theme idref="A7" />
<clue>CONCLUSION: We suggest that Oct1, YY1, and octamer-like factors <clueType>binding</clueType> <linkTheme>to</linkTheme> the -90/-79 sequence within the proximal IL-5 promoter are involved in suppression of IL-5 transcription in T cells.</clue>
</event>
<event id="E37">
<type class="Transcription" />
<theme idref="T54" />
<clue>CONCLUSION: We suggest that Oct1, YY1, and octamer-like factors binding to the -90/-79 sequence within the proximal IL-5 promoter are involved in suppression of IL-5 <clueType>transcription</clueType> in T cells.</clue>
</event>
<event id="E38">
<type class="Negative_regulation" />
<theme idref="E37" />
<clue>CONCLUSION: We suggest that Oct1, YY1, and octamer-like factors binding to the -90/-79 sequence within the proximal IL-5 promoter are involved in <clueType>suppression</clueType> <linkTheme>of</linkTheme> IL-5 transcription in T cells.</clue>
</event>
<event uncertainty="probable" id="E39">
<type class="Regulation" />
<theme idref="E38" />
<cause idref="E34" />
<clue>CONCLUSION: We suggest that Oct1, YY1, and octamer-like factors binding to the -90/-79 sequence within the proximal IL-5 promoter are <clueType>involved</clueType> <linkTheme>in</linkTheme> suppression of IL-5 transcription <clueLoc>in T cells.</clueLoc></clue>
</event>
<event uncertainty="probable" id="E40">
<type class="Regulation" />
<theme idref="E38" />
<cause idref="E35" />
<clue>CONCLUSION: We suggest that Oct1, YY1, and octamer-like factors binding to the -90/-79 sequence within the proximal IL-5 promoter are <clueType>involved</clueType> <linkTheme>in</linkTheme> suppression of IL-5 transcription <clueLoc>in T cells.</clueLoc></clue>
</event>
<event uncertainty="probable" id="E41">
<type class="Regulation" />
<theme idref="E38" />
<cause idref="E36" />
<clue>CONCLUSION: We suggest that Oct1, YY1, and octamer-like factors binding to the -90/-79 sequence within the proximal IL-5 promoter are <clueType>involved</clueType> <linkTheme>in</linkTheme> suppression of IL-5 transcription <clueLoc>in T cells.</clueLoc></clue>
</event>
</AbstractText>
</Abstract>
</Article>
</MedlineCitation>
</PubmedArticle>
</PubmedArticleSet>
</Annotation>
